AL58805

· Advenchen Laboratories Nanjing Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL58805, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AL58805 in Patients With Advanced Tumors [Phase 1]